Evidence and mechanisms for statin-induced cognitive decline

References

• LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. Jama. 1999;282(24):2340–2346.
   PubMed Web of Science ®Google Scholar
• Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;(1).
   Web of Science ®Google Scholar
• Laleman N, Henrard S, van Den Akker M, et al. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study. BMC Cardiovasc Disord. 2018;18(1):209.
   PubMedGoogle Scholar
• Informatics I. The use of medicines in the United States: review of 2010. April ed. IMS Institute for Healthcare Informatics;2011.
   Google Scholar
• Group SSSS. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet. 1994;344(8934):1383–1389.
   PubMed Web of Science ®Google Scholar
• Thompson PD, Panza G, Zaleski A, et al. Statin-associated side effects. J Am Coll Cardiol. 2016;67(20):2395–2410.
   PubMed Web of Science ®Google Scholar
• Golomb BA, Evans MA. Statin adverse effects. Am J Cardiovasc Drugs. 2008;8(6):373–418.
   PubMed Web of Science ®Google Scholar
• Richardson GR, Sullivan JP, Lee RM, et al. Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance. Clin Cardiol. 1992;15:426–432.
   PubMedGoogle Scholar
• Muldoon MF, Barger SD, Ryan CM, et al. Effects of lovastatin on cognitive function and psychological well-being. Am J Med. 2000;108:538–546.
   PubMed Web of Science ®Google Scholar
• Muldoon MF, Ryan CM, Sereika SM, et al. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med. 2004;117(11):823–829.
   PubMed Web of Science ®Google Scholar
• Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacother J Human Pharmacol Drug Ther. 2009;29(7):800–811.
   Google Scholar
• A O, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacother J Human Pharmacol Drug Ther. 2001;21(6):767–769.
   Google Scholar
• King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacother J Human Pharmacol Drug Ther. 2003;23(12):1663–1667.
   Google Scholar
• Wagstaff LR, Mitton MW, Arvik BM, et al. Statin‐associated memory loss: analysis of 60 case reports and review of the literature. Pharmacother J Human Pharmacol Drug Ther. 2003;23(7):871–880.
   Google Scholar
• Graveline D. Lipitor, thief of memory: statin drugs and the misguided war on cholesterol. Haverford, PA: Infinity Pub; 2004.
   Google Scholar
• L G, Polimeni G, Salvo F, et al. Short-term memory loss associated with rosuvastatin. Pharmacother J Human Pharmacol Drug Ther. 2006;26(8):1190–1192.
   Google Scholar
• Parker BA, Polk DM, Rabdiya V, et al. Changes in memory function and neuronal activation associated with atorvastatin therapy. Pharmacother J Human Pharmacol Drug Ther. 2010;30(6):236e–240e.
   Google Scholar
• FDA drug safety communication: important safety label changes to cholesterol-lowering statin drugs 2016. [cited 2017 Aug 08]. Retrived from https://www.fda.gov/Drugs/DrugSafety/ucm293101.htm
   Google Scholar
• Ott BR, Daiello LA, Dahabreh IJ, et al. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med. 2015;30(3):348–358.
   PubMed Web of Science ®Google Scholar
• Mach F, Ray KK, Wiklund O, et al. Adverse effects of statin therapy: perception vs. the evidence–focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526–2539.
   PubMed Web of Science ®Google Scholar
• Chuang CS, Lin CL, Lin MC, et al. Decreased prevalence of dementia associated with statins: a national population‐based study. Eur J Neurol. 2015;22(6):912–918.
   PubMed Web of Science ®Google Scholar
• Lavie C, DiNicolantonio J, O‘Keefe J, et al. Do statins cause or prevent dementia? Eur J Neurol. 2015;22(6):885.
   PubMed Web of Science ®Google Scholar
• Zandi PP, Sparks DL, Khachaturian AS, et al. Do statins reduce risk of incident dementia and Alzheimer disease? The cache county study. Arch Gen Psychiatry. 2005;62(2):217–224.
   PubMed Web of Science ®Google Scholar
• Simons M SF, Lutjohann D, et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer‘s Disease: a 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol. 2002;52:346–350.
   PubMed Web of Science ®Google Scholar
• Sparks D, Connor DJ, Browne PJ, et al. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer‘s Disease and why it would be ill-advised to use one that crosses the blood-brain barrier. J Nutr Health Aging. 2002;6:324–331.
   PubMedGoogle Scholar
• Harrison RW, Ashton CH. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin and placebo in healthy volunteers. Br J Clin Pharmacol. 1994;37:231–236.
   PubMed Web of Science ®Google Scholar
• Kotsis JB, R R, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol. 1994;34:989–996.
   PubMed Web of Science ®Google Scholar
• Cutler N, Sramek J, Veroff A, et al. Effects of treatmetn with simvastatin and pravastatin on cognitive function in patients with hypercholesterolemia. Br J Clin Pharmacol. 1995;39:333–336.
   PubMed Web of Science ®Google Scholar
• F G, Cwudzinski D, Kindel P, et al. Effects of treatment with lovastatin and pravastatin on daytime cognitive performance. Clin Cardiol. 1995;18:209–214.
   PubMed Web of Science ®Google Scholar
• Santanello NC, Barber BL, Applegate WB, et al. Effect of pharmacologic lipid lowering on health‐related quality of life in older persons: results from the cholesterol reduction in seniors program (CRISP) pilot study. J Am Geriatr Soc. 1997;45(1):8–14.
   PubMed Web of Science ®Google Scholar
• Group HPSC. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360: 7–22.
   PubMed Web of Science ®Google Scholar
• Shepard J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet. 2002;360:1623–1630.
   PubMed Web of Science ®Google Scholar
• Benito-Leon J, Louis ED, Vega S, et al. Statins and cognitive functionining in the elderly: a population-based study. J Alzheimer‘S Dis. 2010;21:95–102.
   PubMedGoogle Scholar
• Prajapati S, Desai CK, Dikshit RK. An evaluation of the effect of atorvastatin on memory and psychomotor function in hypertensive patients. J Postgrad Med. 2011;57(4):291–297.
   PubMed Web of Science ®Google Scholar
• O’Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65(7):963–967.
   PubMed Web of Science ®Google Scholar
• Simard M. The mini-mental state examination: strengths and weaknesses of a clinical instrument. Can Alzheimer Dis Rev. 1998;12:10–12.
   Google Scholar
• Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests: administration, norms, and commentary. New York, NY: Oxford University Press; 2006.
   Google Scholar
• Pase MP, Stough C. An evidence-based method for examining and reporting cognitive processes in nutrition research. Nutr Res Rev. 2014 Dec;27(2):232–241. . PubMed PMID: 25268900.
   PubMed Web of Science ®Google Scholar
• Pase MP, Grima N, Cockerell R, et al. The effects of long-chain omega-3 fish oils and multivitamins on cognitive and cardiovascular function: a randomized, controlled clinical trial. J Am Coll Nutr. 2015;34(1):21–31.
   PubMed Web of Science ®Google Scholar
• Stough C, Pase MP. Improving cognition in the elderly with nutritional supplements. Curr Dir Psychol Sci. 2015;24(3):177–183.
   Web of Science ®Google Scholar
• Spindler M, Beal MF, Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009;5:597–610. PubMed PMID: 19966907; PubMed Central PMCID: PMCPMC2785862.
   PubMed Web of Science ®Google Scholar
• Ishrat T, Khan MB, Hoda MN, et al. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav Brain Res. 2006 Jul 15;171(1):9–16. PubMed PMID: 16621054.
   PubMed Web of Science ®Google Scholar
• Martin SB, Cenini G, Barone E, et al. Coenzyme Q10 and cognition in atorvastatin treated dogs. Neurosci Lett. 2011 Aug 26;501(2):92–95. PubMed PMID: 21763754; PubMed Central PMCID: PMCPMC3174091.
   PubMed Web of Science ®Google Scholar
• Sumien N, Heinrich KR, Shetty RA, et al. Prolonged intake of coenzyme Q10 impairs cognitive functions in mice. J Nutr. 2009 Oct;139(10):1926–1932. PubMed PMID: 19710165; PubMed Central PMCID: PMCPMC2744613.
   PubMed Web of Science ®Google Scholar
• Rojas-Fernandez CH, Cameron J-CF. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012;46(4):549–557.
   PubMed Web of Science ®Google Scholar